Physician

Robert Wayne Cox, MD

According to 2025 Medicare claims, Robert Cox, MD (NPI: 1164480026) practices family practice in the Greenville, NC market, with the plurality of this provider's patient population coming from Pitt, NC. This provider's primary affiliated billing organization is PHYSICIANS EAST, P.A. (NPI: 1598761967; TIN: 561968491) and primary practice location at 27834-5704. Cox is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Cox's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 625 traditional Medicare patients, billed 24,126 HCPCS/CPT codes, and received $398,101 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,884 prescription claims across 790 beneficiaries totaling $828,499 in drug costs, led by Eliquis (Apixaban). DME data shows 56 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $500,653 to $828,499. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $28,361 to $1,862.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	714	20,333	$344,886
2016	739	21,779	$361,234
2017	775	26,620	$388,913
2018	701	23,366	$383,003
2019	683	24,001	$381,007
2020	716	21,223	$356,054
2021	689	27,178	$419,616
2022	610	21,677	$395,098
2023	641	26,647	$412,971
2024	625	24,126	$398,101

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	450	10,114	$500,653
2016	507	10,383	$538,259
2017	499	10,205	$533,409
2018	503	10,624	$565,685
2019	511	10,874	$623,942
2020	544	10,953	$680,961
2021	603	11,147	$667,571
2022	673	11,289	$670,826
2023	855	12,652	$892,385
2024	790	13,884	$828,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	153	402	$9,826
2016	103	372	$9,736
2017	51	231	$5,447
2018	50	314	$13,329
2019	53	212	$8,149
2020	23	144	$2,596
2021	15	75	$1,652
2022	16	65	$725
2023	11	37	$472
2024	N/R	56	$723

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	491	1,895	$87
84443	Blood test, thyroid stimulating hormone (tsh)	452	957	$16
80053	Blood test, comprehensive group of blood chemicals	463	1,079	$10
36415	Insertion of needle into vein for collection of blood sample	470	1,196	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	467	1,109	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	127	5,174	$98,743
Xarelto	Rivaroxaban	62	2,811	$52,128
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	2,145	$43,788
Repatha Sureclick	Evolocumab	58	1,792	$34,869
Jardiance	Empagliflozin	42	1,732	$33,304

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	30	$373
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	14	$336
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	N	N/R	12	$14

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Robert Wayne Cox, MD?

Tedicare shows public-source Medicare data for Robert Wayne Cox, MD (NPI 1164480026), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Wayne Cox, MD have ACO affiliation data?

Robert Wayne Cox, MD is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Robert Wayne Cox, MD?

Robert Wayne Cox, MD is linked to PHYSICIANS EAST, P.A. (billing NPI 1598761967) in the available physician profile data.

Does Robert Wayne Cox, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.